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E-mail address: lmd4@nyu.edu (L. Dejean).Protein–protein interactions between the Bcl2 family proteins regulate apoptosis. An imbalance of
this interaction network due to the upregulation of the proto-oncogene Bcl2 leads to a resistance to
apoptosis associated with tumor formation. Bcl2 overexpression inhibits BAX oligomerization and
mitochondrial outer membrane (MOM) permeabilization. However, Bcl2 effects on earlier steps of
BAX-mediated apoptosis are not fully understood. Bcl2 overexpression inhibits BAX insertion into
the MOM but spontaneously increases BAX relocalization to the mitochondria. Also, a physical inter-
action between BAX and Bcl2 is necessary for these two effects to occur. Taken together, these
results suggest upregulated Bcl2 stabilizes BAX loose binding to mitochondrial membranes, inhibit-
ing its insertion into the MOM and consequently cytochrome c release.
Structured summary
MINT-7945271: BAX (uniprotkb:Q07813) physically interacts (MI:0915) with Bcl-2 (uniprotkb:P10417) by
anti bait coimmunoprecipitation (MI:0006)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Apoptosis is a cell death program in which mitochondria play a
central role. During early apoptosis, permeabilization of the mito-
chondrial outer membrane (MOM) allows the release of pro-apop-
totic factors, like cytochrome c, from the intermembrane space
(IMS) into the cytosol. Cytochrome c release promotes and ampli-
ﬁes the apoptotic cascade; and is considered the commitment step
of programmed cell death [1–4]. Importantly, this event is highly
regulated through speciﬁc interactions between proteins of the
Bcl2 family [1,2,4–9]. In this family, effector proteins such as BAX
are essential to the machinery allowing the permeabilization of
the MOM. On the other hand, anti-apoptotic members such as
Bcl2, inhibit this process by directly binding to the pro-apoptotic
effector proteins [5]. Finally, BH3-only proteins relay apoptotic
stimuli to the mitochondria by interacting with both effectors
and anti-apoptotic Bcl2 family members [1,2,5]. Therefore, when
challenged by an apoptotic stimulus, the combined signaling
within the Bcl2 family dictates the immediate fate of the cell, i.e.,
to induce permeabilization of the MOM or not [1].
An imbalance inside the Bcl2 family proteins interaction net-
work, e.g., through the variation of the expression level of its com-chemical Societies. Published by E
f Basic Science, College of
w York City, NY 10010, USA.ponents, may cause pathophysiological situations. In this respect,
genetic events leading to the overexpression of the Bcl2 proto-
oncogene are associated with tumor formation and more particu-
larly B-Cell non-Hodgkin’s lymphoma [10–12]. Also, prolymphocy-
tic cell lines overexpressing Bcl2 exhibit both resistance to
mitochondrial apoptosis and the ability to induce lymphoma after
injection in mice [10,13–15]. Interestingly, it was recently shown
that an over-abundance of the Bcl2 protein caused the sequestra-
tion of some pro-apoptotic BH3-only proteins in mitochondria.
This accumulation of activator BH3-only proteins has been de-
scribed as a ‘priming for death’, and this concept is currently used
to develop new strategies to selectively kill cancer cells [16,17]. Fi-
nally, Bcl2 overexpression induces inhibition of mitochondrial
apoptosis that requires a physical interaction between Bcl2 and
the pro-apoptotic protein BAX [18,19].
Early apoptosis consists in a speciﬁc chain of events exquisitely
regulated by Bcl2 family proteins which are leading to MOM per-
meabilization. The translocation of cytosolic BAX to the mitochon-
dria occurs in response to an apoptotic stimulus. BAX then
undergoes a conformational change that leads to the exposure of
its N-terminus, and is inserted into the MOM [1,2,4–9]. BAX was
also shown to form oligomers in mitochondrial membranes during
apoptosis [20]. These BAX oligomers are essential constituents of
MAC, the apoptotic channel responsible for cytochrome c release
[15,21,22]. On the other hand, Bcl2 is an anti-apoptotic protein
normally inserted into the MOM. It is now well established thatlsevier B.V. All rights reserved.
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inhibition of BAX oligomerization and MAC activity [10–15,23].
However, the effects of Bcl2 on the earlier steps of the BAX-
mediated apoptotic pathway remain poorly understood.
In this study, we report that resistance to mitochondrial apop-
tosis conferred by Bcl2 overexpression is primarily associated with
inhibition of BAX insertion into the MOM. Interestingly, however,
mitochondrial BAX levels were signiﬁcantly increased in non-
apoptotic cells overexpressing Bcl2; up to levels equivalent to
those observed in apoptotic parental cells. Also, this spontaneous
increase in Bcl2-mediated BAX relocalization at the mitochondria
was dependent upon the ability of Bcl2 to physically interact with
BAX. Taken together, these results suggest upregulated Bcl2 stabi-
lizes BAX loose binding to mitochondrial membranes, inhibiting its
insertion into the MOM and consequently cytochrome c release.
2. Materials and methods
2.1. Cells, growth conditions, and induction of apoptosis
The hematopoietic FL5.12 parental, Bcl2 overexpressing, and
Bcl2-G145E overexpressing cell lines were grown as previously de-
scribed [15]. Apoptosis was induced by 12 h of IL-3 withdrawal
[14,15].
2.2. Cytochrome c release assay
Cytosolic cytochrome c from digitonin-permeabilized normal or
apoptotic cells was quantiﬁed by ELISA (Quantikine; R&D Systems,
Mineapolis, MN), as described by [21,22].
2.3. Isolation of mitochondria
Mitochondria were isolated and resuspended in mitochondrial
buffer (230 mM mannitol, 70 mM sucrose, 1 mM EDTA, 5 mM
HEPES-KOH, pH 7.4), as previously described [15].
2.4. Isolation of MOM-inserted BAX
Membrane-inserted mitochondrial proteins were isolated by
centrifugation after removing the proteins loosely bound to the
mitochondrial outer membrane by an alkaline treatment with
0.1 M Na2CO3, pH 11, as described in [20].
2.5. Whole cell protein extraction and sub-cellular fractionation
Whole cell protein extraction: Total cell proteins were solubilized
by an incubation of 30 min in lysis buffer (PBS supplemented with
1% (v/v) Triton X-100). Sub-cellular fractionation: Cytosolic and
mitochondrial fractions were obtained by differential centrifuga-
tion, as previously described by [13].
2.6. Antibodies
Primary antibodies: anti Bax (N20, Santa Cruz Biotechnology,
Inc., 1:2500), anti VDAC1 (Ab-1, Calbiochem, 1:2500), anti Bcl2
(C2, Santa Cruz Biotechnology, Inc., 1:2000). Secondary antibodies:
goat anti-rabbit (1:5000) and anti-mouse (1:2500) HRP-coupled
(Santa Cruz Biotechnology, Inc.).
2.7. Calculation of the amount ofmitochondrial andMOM-inserted BAX
Non-saturated Western blots for BAX and VDAC1, a protein na-
tively inserted in the mitochondrial outer membrane, were
scanned and quantiﬁed with Image J software. The average ratioof BAX relative to VDAC1 was calculated for each condition. These
BAX/VDAC1 ratios were normalized to that of the parental condi-
tion which was arbitrarily ﬁxed at 1.
2.8. Immunoprecipitation assays
Mitochondrial proteins were solubilized in mitochondrial buffer
containing 2% CHAPS as previously described [20]. Total soluble
BAX was detected byWestern blot, and quantiﬁed by densitometry
using increasing amount of recombinant BAX (a gift from Bruno
Antonsson) as standards [21]. After quantiﬁcation, the same
amounts of total BAX were immunoprecipitated with an antibody
recognizing a BAX epitope known to be exposed during early apop-
tosis (N20-AC, Santa Cruz Biotechnology, Inc.), as previously de-
scribed by [21]. Alternatively, these lysates were also incubated
with an antibody against all forms of BAX (5B7, Sigma–Aldrich,
St. Louis, MO).3. Results
3.1. Bcl2 overexpression inhibits BAX insertion but does not modify
mitochondrial BAX levels during apoptosis
It is nowwell established that Bcl2 overexpression inhibits apop-
tosis through the inhibition of MAC formation and activity
[13,15,23]. However, the effects of an excess of Bcl2 on earlier steps
ofBAX-mediatedapoptoticpathwaybegged further investigation. In
this study, early apoptosis was induced in pro-lymphocytic FL5.12
cellsby12 hof IL-3withdrawal [24,25] inorder to analyze theeffects
of Bcl2 overexpression on mitochondrial cytochrome c release;
and BAX translocation, conformational change (resulting in the
exposure of BAX N-terminal region), and insertion into the MOM.
IL-3 withdrawal triggered the release of cytochrome c by mito-
chondria of parental FL5.12, leading to a fourfold increase of
cytosolic cytochrome c in this cell line (i.e., from 30 ± 1 to
120 ± 10 pmol cytochrome c/million cells, n = 4, not shown). This
release was about 90% reduced in Bcl2 overexpressing FL5.12 cells
(Bcl2) (Fig. 1A); a result which was in agreement with Bcl2 inhibi-
tion of MOM permeabilization during apoptosis [13,15,23]. BAX
translocation was estimated by quantiﬁcation of the total mito-
chondrial BAX content. In agreement with previous reports [15],
mitochondrial BAX content increased in parental cells after IL-3
withdrawal (Fig. 2A). Interestingly, the amount of BAX inmitochon-
driawas similar in both parental and Bcl2 overexpressing cells (Bcl2
cells) after IL-3 withdrawal (Fig. 1B). The change of conformation of
BAX was detected using antibodies against a speciﬁc N-terminus
epitope known to be exposed during early apoptosis [26]. Similar
to that observed for total BAX, BAX conformational change levels
increased in apoptotic parental cells (Fig. 2D). In addition, mito-
chondria of IL-3 starved parental and Bcl2 cells did not show a sig-
niﬁcant difference in the amount of BAXwhich underwent a change
of conformation (Fig. 1C). Finally, the amount of BAX inserted into
the MOM was about 70% reduced in Bcl2 cells (Fig. 1D). Taken to-
gether, all these results showed that, during apoptosis, mitochon-
drial cytochrome c release, BAX insertion, conformational change,
and insertion were inhibited by Bcl2 overexpression. However,
the similar BAX levels in mitochondria of both cell types strongly
suggested that Bcl2-mediated strong inhibition of BAX insertion
was crucial in inhibiting cytochrome c release.
3.2. Bcl2 overexpression increases BAX relocalization and change of
conformation in mitochondria in the absence of apoptotic stimulus
The fact that both total and conformationally changed (N20 po-
sitive) BAX levels were similar in parental and Bcl2 cells after
Fig. 1. Effects of Bcl2 overexpression on early mitochondrial markers of the BAX-mediated apoptotic pathway. Apoptosis was induced by 12 h of IL-3 withdrawal in parental
(open bars) and Bcl2 overexpressing (Bcl2, closed bars) FL5.12 cells. Data from Bcl2 cells were quantiﬁed by densitometry, normalized relative to parental cells (see Section 2),
and shown as ±S.E.M. Statistically signiﬁcant differences, if any, between parental and Bcl2 overexpressing conditions, were determined by Student’s t-test and shown as *. (A)
Cytosolic cytochrome c from digitonin-permeabilized apoptotic parental and Bcl2 cells was quantiﬁed by ELISA as described in Section 2 (* corresponds to p < 0.05, n = 4). (B)
Mitochondrial BAX content. The presence of mitochondrial BAX and VDAC1 in isolated mitochondria was detected by Western blot [top], and the average mitochondrial BAX/
VDAC1 ratio was determined as described in Section 2 (n = 17) [bottom]. (C) BAX conformational change. Total mitochondrial proteins were solubilized in the presence of 2%
CHAPS and equal amounts of total BAX were immunoprecipitated with an antibody recognizing a conformation of BAX associated with early apoptosis (N20). The
immunoprecipitated BAX was detected by Western blot [top], and was quantiﬁed by densitometry (n = 15) [bottom]. (D) BAX insertion. Inserted BAX and VDAC1 were
immunodetected in sodium carbonate-treated mitochondria [top] as described in Section 2. The average mitochondrial BAX/VDAC1 ratio was quantiﬁed by densitometry
(* corresponds to p < 0.05, n = 18) [bottom].
O. Teijido, L. Dejean / FEBS Letters 584 (2010) 3305–3310 3307apoptotic stimulation (Fig. 1B and C) suggested that Bcl2 was a po-
sitive regulator of mitochondrial BAX content. In agreement with
this hypothesis, mitochondrial BAX content in Bcl2 cells grown in
the presence of IL-3 (normal Bcl2 cells) was twofold higher than
that in normal parental cells, reaching values similar to those ob-
served in apoptotic parental cells (Fig. 2A). This Bcl2-mediated
BAX increase in mitochondria was associated to a concomitant de-
crease of cytosolic BAX levels as indicated by a higher mitochon-
drial BAX/cytosolic BAX ratio in Bcl2 cells (Fig. 2B). Also, this
effect was not due to an increase of the total cellular BAX content
as Bcl2 overexpression had no inﬂuence on the total amount of
BAX per cell (Fig. 2C). These data indicate that the higher levels
of mitochondrial BAX content in Bcl2 cells was associated to a
mitochondrial relocalization of BAX which was independent of
the presence of an apoptotic stimulus. Interestingly, mitochondria
of Bcl2 cells grown in the presence of IL-3 also showed similar N20
positive BAX amounts to that of apoptotic parental cells; i.e., BAXamounts which were between two and threefold higher than those
of control parental cells (Fig. 2D). All these results indicated that an
increase of mitochondrial Bcl2 content was able to stimulate BAX
mitochondrial relocalization and change of conformation in the ab-
sence of an apoptotic stimulus.
3.3. Bcl2 overexpression induces a spontaneous increase of BAX
mitochondrial content which depends on Bcl2 ability to interact with
BAX
As protein–protein interactions are essential to the regulation of
Bcl2 family proteins, we ﬁnally tested the impact of Bcl2/BAX
interaction on the increase of mitochondrial BAX content and
change of conformation observed in Bcl2 cells. For that purpose,
these two parameters were assessed in mitochondria from FL5.12
cells overexpressing a Bcl2 mutant (G145E cells) which is unable
to physically interact with BAX [19] (Fig. 3A). The spontaneous
Fig. 2. Bcl2 overexpression enhances both BAX translocation and change of conformation in mitochondria of normal cells. Parental (open bars) and Bcl2 overexpressing
FL5.12 cells (Bcl2, closed bars) were grown in the presence (B and C), or in the presence or absence of IL-3 (A and D). Data from Bcl2 cells were quantiﬁed by densitometry,
normalized relative to parental cells (see Section 2), and shown as ±S.E.M. Statistically signiﬁcant differences, if any, between parental and Bcl2 overexpressing conditions,
were determined by Student’s t-test and shown as *. (A) Mitochondrial BAX content. The presence of mitochondrial BAX and VDAC1 in isolated mitochondria was detected by
Western blot [top], and the average mitochondrial BAX/VDAC1 ratio was quantiﬁed by densitometry as described in Section 2 (* indicates p < 0.05, n = 17) [bottom]. (B) BAX
distribution. BAX immunodetection in cytosolic (BAXCyt) and mitochondrial (BAXMito) fractions from parental and Bcl2 cells [top]. Histogram shows the mitochondrial/
cytosolic BAX signal ratio for both parental and Bcl2 cells [bottom]. These results are representative of three independent experiments. (C) Cellular BAX content. Total proteins
from the same amounts of parental and Bcl2 cells were solubilized in the presence of 1% Triton X-100. BAX was immunodetected [top] and quantiﬁed by densitometry. This
quantiﬁcation was normalized per cell (n = 14) [bottom]. (D) BAX conformational change. Total mitochondrial proteins were solubilized and immunoprecipitated with an
antibody recognizing a conformation of BAX associated with early apoptosis (N20) as described in Fig. 1C. Immunoprecipitated activated BAX was detected by Western blot
[top] and quantiﬁed by densitometry (* corresponds to p < 0.05, n = 15) [bottom].
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of conformation in Bcl2 cells, were abolished in G145E cells (Fig. 3B
and C). This result indicated that Bcl2 is required to physically
interact with BAX, at least through its BH1 domain [19], in order
to increase both total and N20 positive BAX amounts in mitochon-
dria of non-apoptotic Bcl2 cells.
4. Discussion
Bcl2 overexpression has now long been associated with lympho-
magenesis and inhibition of BAX-mediated apoptosis [10–15,23].
However, the effects of Bcl2 on early steps of intrinsic apoptosis
like BAX mitochondrial relocalization, insertion and change of con-
formation remained poorly documented and were the main focus
of this work. Prolymphocytic FL5.12 cells overexpressing Bcl2
(Bcl2 cells), known for their aptitude to induce lymphoma when
injected in mice [10], were the model chosen for our study. Apop-
tosis was induced by 12 h of IL-3 deprivation [24,25], as classicmarkers of mitochondrial apoptosis from BAX translocation to
detection of MAC activity were detected in those cells at this time
[4,13–15,24].
Bcl2 overexpression inhibited both, BAX insertion into the MOM
(Fig. 1C), and cytochrome c release (Fig. 1A) when cells were apop-
totically challenged. These results are in agreement with the inhib-
itory effects of an excess of Bcl2 on MAC formation and activity
during mitochondrial apoptosis [15,20,21,23]. Bcl2 overexpression
was originally shown to inhibit BAX mitochondrial relocalization
triggered by an apoptotic stimulus [13,14]. Also, BclxL was shown
recently to inhibit both of these processes in isolated mitochondria
[29]. We conﬁrmed these results as no differences in mitochondrial
total and conformationally changed BAX contents were detected
between normal and IL-3 deprived Bcl2 cells (compare Figs. 1B
and 2A; and Figs. 1C and 2D). However and importantly, IL-3-
deprived Bcl2 cells showed also similar mitochondrial total or
conformationnally changed BAX contents to those of apoptotic
parental cells (Fig. 1B and C). Thus, Bcl2-mediated inhibition of
Fig. 3. The lack of Bcl2/BAX interaction abolishes Bcl2-mediated increase of BAX mitochondrial content and change of conformation. Three different FL5.12 cell types were
grown in the presence of IL-3: parental cells (parental), cells overexpressing Bcl2 (Bcl2) and cells overexpressing a Bcl2 mutant which is unable to interact with BAX (G145E).
Data from Bcl2 and G145E cells were quantiﬁed by densitometry, normalized relative to parental cells (see Section 2), and shown as ±S.E.M. Statistically signiﬁcant
differences, if any, between parental and Bcl2 overexpressing conditions, were determined by Student’s t-test and shown as *. (A) Bcl2/BAX interaction. Mitochondrial CHAPS
lysates from Bcl2 and G145E cells containing equal amount of BAX were immunoprecipitated with an antibody recognizing all BAX conformations (5B7). The presence of BAX
and Bcl2 in the pellets containing the immunoprecipitated proteins was assessed by Western blot. The minor band in the G145E lane for Bcl2 is likely to correspond to the
endogenous Bcl2 in this cell line. (B) Mitochondrial BAX content. Western blots show levels of BAX and VDAC1 in isolated mitochondria from parental, Bcl2 and G145E cells
[top]. The average mitochondrial BAX/VDAC1 ratio was quantiﬁed by densitometry as described in Section 2 (* indicates p < 0.05, n = 7) [bottom]. (C) BAX conformational
change. Total mitochondrial proteins from parental, Bcl2 and G145E cells were solubilized with 2% CHAPS and equal amounts of total BAX were immunoprecipitated with an
anti-BAX antibody recognizing a conformation of BAX associated with early apoptosis (N20). The presence of activated BAX in the pellets containing the immunoprecipitated
proteins was assessed by Western blot [top]. The average activated BAX was quantiﬁed by densitometry (n = 11) [bottom].
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unlikely to constitute the primary events leading to apoptosis
blockade as previously suggested by [13,14]. In fact, Bcl2 overex-
pression was rather determining in blocking mitochondrial apop-
tosis downstream of BAX change of conformation and upstream
of BAX insertion. This observation was in agreement with the
notion that, during apoptosis, BAX conformational change occurs
previous to BAX insertion, as previously suggested by [5,27] and
recently indicated by [37]. Finally, and as several studies indicate
BAX oligomerization occurs inside the MOM [22,28], our results
also strongly suggest that Bcl2-mediated inhibition of BAX inser-
tion is the most determining step of the process leading to the
blocking of cytochrome c release.
Another interesting observation of our study was that the total
BAX content in mitochondria from normal Bcl2 cells was higher
than that of normal parental cells (Fig. 2A). This elevation was
the result of a spontaneous BAX mitochondrial relocalization
(Fig. 2B) that required an interaction between Bcl2 and BAX; this
effect was not observed when Bcl2/BAX interaction was disrupted
in the Bcl2 mutant G145E (Fig. 3A and B). Of note, transient highexpression levels of Bcl2 were reported to lead to MOM permeabi-
lization; an effect which was partially reversed by the mutation
G145E [30,31]. We show however that a stable overexpression of
Bcl2 is not pro-apoptotic per se, and that it even makes the cells
resistant to IL-3-induced apoptosis (Fig. 1A). The latent pro-apop-
totic function of Bcl2 reported in [30,31] may nevertheless contrib-
ute to the increase of mitochondrial BAX in non-apoptotic cells
observed during our study (Fig. 3B and C). Our ﬁndings also suggest
that Bcl2 can stabilize BAX loose association at the MOM level
through direct physical interaction. Other proteins integral to the
MOM, like the subunit of the protein import complex TOM,
Tom22, were previously shown to have a similar function [32–34].
Importantly, these proteins are natural pro-apoptotic receptors
for BAX in the mitochondria. On the other hand, Bcl2 was shown
to sequester the nuclear orphan receptor Nur77 at the mitochon-
dria; an interaction leading to the conversion of Bcl2 into a
pro-apoptotic protein which eventually trigger BAX conforma-
tional change and MOM permeabilization [35,36]. The results of
our experiments also suggest that Bcl2 can behave as a BAX decoy
receptor, stabilizing BAX at the MOM in order to inhibit further
3310 O. Teijido, L. Dejean / FEBS Letters 584 (2010) 3305–3310apoptotic steps. Moreover, BAX conformational change was also in-
creased in mitochondria of normal Bcl2 cells in a Bcl2/BAX interac-
tion-dependant way (Figs. 2D and 3C). Strikingly, the levels of
conformationally changed BAX in mitochondria of Bcl2 cells were
actually similar to those observed in mitochondria of parental cells
dying by apoptosis (Fig. 1B). It has been reported that this speciﬁc
form of BAX does not interact with Bcl2 [26]. It was also recently
shown that BAX N-terminal exposure was not essential to BAX
insertion and cytochrome c release, but rather correlates with
mitochondrial targeting [37]. These observations indicate that
BAX conformational change through the exposure of its N-termi-
nus is not a controlling step of MOM permeabilization (as also pre-
viously suggested by [5]), but rather a marker of BAX stabilization
at the MOM level. Taken together, our results then strongly suggest
that Bcl2 overexpression indirectly increases BAX conformational
change levels at the MOM level through BAX stabilization.
In cancer cells that overexpress Bcl2, the protein itself is often
largely bound to pro-apoptotic BH3-only proteins like BIM. In such
circumstances, Bcl2 and the cells are described as being ‘primed for
death’, and this characteristic is currently exploited to design new
drugs (e.g., ABT-737) which selectively kill cancer cells [17]. This
phenomenon has also been described in FL5.12 cells overexpress-
ing Bcl2 in which BIM was shown to be abnormally accumulated
at the mitochondrial level [16]. Interestingly, BIM was also recently
shown to directly interact with BAX; this interaction leads to mem-
brane permeabilization and cytochrome c release [38]. In our
study, we show that Bcl2 overexpression leads also to an abnormal
accumulation of BAX in mitochondria (Figs. 2 and 3). This observa-
tion suggests that the ‘‘primed for death” status induced by Bcl2
overexpression might also involve multidomain effector members
of the Bcl2 family proteins, such as BAX. The analysis of this pecu-
liar new type of ‘‘addiction” to the anti-apoptotic proteins should
then prove to be critical to understand the mechanisms by which
cancer cells maintain survival.
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